NO975636L - Pharmaceutical composition for promoting osteogenesis - Google Patents

Pharmaceutical composition for promoting osteogenesis

Info

Publication number
NO975636L
NO975636L NO975636A NO975636A NO975636L NO 975636 L NO975636 L NO 975636L NO 975636 A NO975636 A NO 975636A NO 975636 A NO975636 A NO 975636A NO 975636 L NO975636 L NO 975636L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
promoting osteogenesis
osteogenesis
promoting
prophylactic
Prior art date
Application number
NO975636A
Other languages
Norwegian (no)
Other versions
NO975636D0 (en
Inventor
Tetsuo Hoshino
Hiroya Muranishi
Shigehisa Taketomi
Susumi Iwasa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO975636D0 publication Critical patent/NO975636D0/en
Publication of NO975636L publication Critical patent/NO975636L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyethers (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det ble fremskaffet en farmasøytisk sammensetning omfattende et non-peptid osteogenetisk fremmende stoff og en biodegraderbar polymer som kan bli sikkert benyttet som et profylaktisk/terapeutisk middel for forskjellige bensykdommer (f.eks. benfrakturer).A pharmaceutical composition comprising a non-peptide osteogenetic promoter and a biodegradable polymer was provided which can be safely used as a prophylactic / therapeutic agent for various bone disorders (e.g., bone fractures).

NO975636A 1995-06-05 1997-12-04 Pharmaceutical composition for promoting osteogenesis NO975636L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13803695 1995-06-05
JP1168696 1996-01-26
PCT/JP1996/001506 WO1996039134A1 (en) 1995-06-05 1996-06-04 Osteogenetic promoting pharmaceutical composition

Publications (2)

Publication Number Publication Date
NO975636D0 NO975636D0 (en) 1997-12-04
NO975636L true NO975636L (en) 1998-01-28

Family

ID=26347166

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975636A NO975636L (en) 1995-06-05 1997-12-04 Pharmaceutical composition for promoting osteogenesis

Country Status (11)

Country Link
EP (1) EP0831808A1 (en)
KR (1) KR19990022514A (en)
AR (1) AR003001A1 (en)
AU (1) AU717260B2 (en)
CA (1) CA2221784A1 (en)
HU (1) HUP9802573A3 (en)
NO (1) NO975636L (en)
NZ (1) NZ308658A (en)
RU (1) RU2188011C2 (en)
TW (1) TW420608B (en)
WO (1) WO1996039134A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008517A2 (en) * 1996-08-26 1998-03-05 Takeda Chemical Industries, Ltd. Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
AU4165699A (en) * 1998-06-15 2000-01-05 Takeda Chemical Industries Ltd. Composition for treating cartilage disease
AU5194999A (en) 1998-08-07 2000-02-28 Takeda Chemical Industries Ltd. Benzothiepin derivatives, process for the preparation of the same and uses thereof
WO2000009100A2 (en) * 1998-08-12 2000-02-24 Takeda Chemical Industries, Ltd. Benzothiepine compounds as enhancer of cell differentiation induction factor
WO2001089521A1 (en) * 2000-05-23 2001-11-29 Takeda Chemical Industries, Ltd. Medicinal compositions containing thiophene derivatives
US6926903B2 (en) * 2001-12-04 2005-08-09 Inion Ltd. Resorbable polymer composition, implant and method of making implant
JP4723864B2 (en) * 2002-12-19 2011-07-13 日本曹達株式会社 Agricultural microcapsule formulation by oil / water drying method and method for producing the same
EP2424488B1 (en) 2009-04-27 2023-06-07 Premier Dental Products Company Microencapsulated compositions and methods for tissue mineralization
US9814657B2 (en) 2009-04-27 2017-11-14 Premier Dental Products Company Buffered microencapsulated compositions and methods
TWI458503B (en) * 2013-04-22 2014-11-01 Medical & Pharm Ind Tech & Dev Vitamin k2 microsphere, manufacture method, use, and drug thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE203020T1 (en) * 1990-05-30 2001-07-15 Takeda Chemical Industries Ltd SULFUR CONTAINING HETEROCYCLIC COMPOUNDS
US5716944A (en) * 1994-07-04 1998-02-10 Takeda Chemical Industries, Ltd. Phosphonic acid compounds, their production and use
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use

Also Published As

Publication number Publication date
NO975636D0 (en) 1997-12-04
AU5845796A (en) 1996-12-24
KR19990022514A (en) 1999-03-25
HUP9802573A3 (en) 2000-04-28
CA2221784A1 (en) 1996-12-12
EP0831808A1 (en) 1998-04-01
NZ308658A (en) 1999-10-28
HUP9802573A2 (en) 1999-09-28
RU2188011C2 (en) 2002-08-27
AR003001A1 (en) 1998-05-27
AU717260B2 (en) 2000-03-23
WO1996039134A1 (en) 1996-12-12
TW420608B (en) 2001-02-01

Similar Documents

Publication Publication Date Title
NO20063853L (en) Combination therapy for osteoporosis
NO20032036L (en) Combinations of medications (eg chlorpromazine and pentamidines) for the treatment of neoplastic disorders
DE60020613D1 (en) (S, S) reboxetine for the treatment of fibromyalgia and other somatoform disorders
DK1036059T3 (en) adamantane
PT1147083E (en) ARILPIPERAZINYL-CYCLOHEXYLINDOLE DERIVATIVES FOR THE TREATMENT OF DEPRESSION
NO975636L (en) Pharmaceutical composition for promoting osteogenesis
NO980317L (en) Use of Calendula glycosides for the treatment of psoriasis
ES2181017T3 (en) PHARMACEUTICAL COMPOSITION CONTAINING A PROMOTING SUBSTANCE OF OSTEOGENESIS AND A POLYETHYLENE GLYCOL.
NO990440L (en) Preparation that includes mupirocin and chlorhexidine
DK0479093T3 (en) Oligosaccharide derivatives and their use as drugs
GB9521608D0 (en) Pharmaceutical composition
BR9814945A (en) Use of phanquinone for the treatment of alzheimer's disease, pharmaceutical composition and kit
NO20012106D0 (en) Drug for the treatment of bone pathobolism
AU6022400A (en) Exposure method, exposure system, light source, and method of device manufacture
RU94041028A (en) Application of melatonin derivatives for treating desynchronization disorders, pharmaceutical composition
NO953989D0 (en) New polycyclic systems and derivatives thereof, such as neurotransmitter release-seeking agents useful in the treatment of cognitive disorders
IT1289154B1 (en) ISOFLAVONE DERIVATIVES THEIR PREPARATION AND THEIR THERAPEUTIC USE
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
ES2190581T3 (en) 2-OPTICALLY ACTIVE AMINOTETRALINE, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT, ACTIVE IN THE PREVENTION AND TREATMENT OF SEPTIC SHOCK.
NO953846L (en) (S) -alpha-phenyl-2-pyridinethanamine (S) -malate and its use as a drug
NZ332412A (en) use of interleuklin-10 for treating or preventing ischemia-reperfusion injury
AU3406089A (en) Novel strobilurine derivatives, their preparation and their use
DK1235573T3 (en) Combination of riluzole and gabapentin and its use as a drug in the treatment of motor neuron disorders
BR9710992A (en) Anticovulsive derivatives useful in the treatment of psoriasis
NO930858D0 (en) SUBSTANCE THAT CAN STOP BLEEDING, eg. BY SURGICAL AND DENTAL INTERVENTIONS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application